Citius Pharmaceuticals
CTXR • NASDAQ
Citius Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Leonard L. Mazur, with a market cap of $16.1M.
CEOLeonard L. Mazur
Next Earnings
Upcoming earnings announcement for Citius Pharmaceuticals
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.32
Revenue Estimate
$9.9M
Earnings History
Past 12 earnings reports for Citius Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | Q1 2026 | -$0.38Est: -$0.30 | -26.7% | $3.9MEst: $3.5M | +14.2% |  10-Q |
| Dec 23, 2025 | Q4 2025 | -$0.11Est: -$0.24 | +54.2% | -Est: $5.8M | -100.0% | 10-K/A |
| Aug 12, 2025 | Q3 2025 | -$0.80Est: -$0.21 | -281.0% | -Est: $1.9M | -100.0% | 10-Q |
| May 14, 2025 | Q2 2025 | -$1.27Est: $1.30 | -197.7% | - | — | 10-Q |
| Feb 14, 2025 | Q1 2025 | -$1.30Est: -$1.25 | -4.0% | - | — | 10-Q |
| Dec 27, 2024 | Q4 2024 | -$1.72Est: -$2.00 | +14.0% | - | — | 10-K/A |
| Aug 12, 2024 | Q3 2024 | -$1.50Est: -$1.50 | 0.0% | - | — | 10-Q |
| May 14, 2024 | Q2 2024 | -$1.25Est: -$1.25 | 0.0% | - | — | 10-Q |
| Feb 14, 2024 | Q1 2024 | -$1.50 | — | - | — | — |
| Dec 29, 2023 | Q4 2023 | -$1.75 | — | - | — | — |
| Aug 14, 2023 | Q3 2023 | -$1.50 | — | - | — | — |
| May 12, 2023 | Q2 2023 | -$1.75Est: -$0.75 | -133.3% | - | — | — |